title: Serum hyaluronic acid in patients with veno-occlusive disease following bone marrow transplantation.
abstract: The development of hepatic veno-occlusive disease following bone marrow transplantation is associated with high-dose combination cytoreductive therapy. Experimental models have suggested that drug-induced injury to hepatic sinusoidal endothelial cells is involved in the pathogenesis of this syndrome. Hyaluronic acid is a polysaccharide that is metabolized, almost exclusively, by hepatic sinusoidal endothelial cells. The aim of the present study was to evaluate serum hyaluronic acid as a marker for endothelial cell injury in patients with veno-occlusive disease following bone marrow transplantation. Hyaluronic acid was measured in sera from patients with and without veno-occlusive disease using an enzyme-linked protein binding assay. Mean peak serum hyaluronic acid levels were significantly greater in patients who had a diagnosis of VOD compared to those transplant patients who did not, 1173.4 +/- 982.9 vs 444.9 +/- 735.6 ng/ml (P = 0.01). Serial serum samples obtained from a separate cohort of patients also demonstrated that serum hyaluronic acid levels were higher in patients with moderate or severe veno-occlusive disease compared to those with none or mild disease at days 7, 17 and 25 following transplantation (greatest difference at day 25: 366 +/- 327 vs 126 +/- 151, P = 0.01). Serum hyaluronic acid levels are increased in veno-occlusive disease and increase over time in patients with severe disease. Further studies are required to determine if elevated serum hyaluronic acid levels are due to decreased clearance by injured hepatic sinusoidal endothelial cells or increased production from early hepatic fibrogenesis associated with the acute liver injury.
authors.affiliation: Division of Gastroenterology, Emory University School of Medicine, Atlanta, GA, USA.
authors.forename: M W
authors.initials: MW
authors.lastname: Fried
authors.forename: A
authors.initials: A
authors.lastname: Duncan
authors.forename: S
authors.initials: S
authors.lastname: Soroka
authors.forename: D G
authors.initials: DG
authors.lastname: Connaghan
authors.forename: A
authors.initials: A
authors.lastname: Farrand
authors.forename: J
authors.initials: J
authors.lastname: Peter
authors.forename: R M
authors.initials: RM
authors.lastname: Strauss
authors.forename: T D
authors.initials: TD
authors.lastname: Boyer
authors.forename: G B
authors.initials: GB
authors.lastname: McDonald
mesh_terms: D000328:Adult; D015415:Biomarkers / Q000097:blood; D016026:Bone Marrow Transplantation / Q000009:adverse effects*; D004727:Endothelium / Q000293:injuries / Q000473:pathology; D005260:Female; D006504:Hepatic Veno-Occlusive Disease / Q000097:blood / Q000175:diagnosis* / Q000209:etiology; D006801:Humans; D006820:Hyaluronic Acid / Q000097:blood*; D008297:Male; D008875:Middle Aged; D012680:Sensitivity and Specificity; D012720:Severity of Illness Index; D018709:Statistics, Nonparametric
chemical_list: D015415:Biomarkers; D006820:Hyaluronic Acid